04.01.09
Enzymotec Ltd. Migdal HaEmeq, Israel, has received Israel patent office approval for its CardiaBeat composition and production process. The patent (IL 162764) is entitled “Fractionation of phytosterol esters in oil.” CardiaBeat is a lipid-regulating agent, composed of plant sterol esters of omega 3 fatty acids in an omega 3 glyceride matrix. The ingredient has additional pending patents around the world and has already gained New Dietary Ingredient (NDI) status in the U.S., as well as novel food approval in the EU.